Stocks Health care TOI
NASDAQ · Health careOncology Institute, Inc. (TOI)
Oncology Institute, Inc. brought in $587.2M of revenue over the twelve months to June 30, 2026, up 38.4% from a year earlier. It posted a net loss of $36.3M. In fiscal 2025 capital spending exceeded operating cash flow by $27.8M. At June 30, 2026 it held $41.1M in cash against $79.9M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
Watch TOI in 60 secondsWhat Oncology Institute, Inc. does
Oncology Institute, Inc. is registered with the SEC under industry code SIC 8011 (Services-Offices & Clinics of Doctors of Medicine). Its shares trade on NASDAQ under the ticker TOI.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $502.7M | -$60.6M | -$0.54 | -$27.8M |
| 2024 | $393.4M | -$64.7M | -$0.71 | -$30.3M |
| 2023 | $324.2M | -$83.1M | -$0.92 | -$40.9M |
| 2022 | $252.5M | $152K | -$0.21 | -$67.3M |
| 2021 | $203M | -$10.9M | -$0.16 | -$35.5M |
| 2020 | $187.5M | -$14.3M | -$0.24 | -$686K |
Full financial statements: income, balance sheet and cash flow
Where TOI ranks in Health care
Latest SEC filings
What Oncology Institute, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 2, 2026
- August 21, 2026
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 35% to $161.3M versus the same quarter last year; diluted EPS -$0.08 versus -$0.15.
- August 6, 2026
- August 3, 2026
- July 7, 2026
- June 18, 2026
- May 22, 2026
- May 15, 2026Activist stake changed SCHEDULE 13D/A
- May 7, 2026
Insider trades
What the people running Oncology Institute, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $78.5K and sold $1.9M worth of shares in the last 90 days. All of the selling was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 21, 2026 | Hively BradDirector | Soldpre-planned (10b5-1) | 298,853 | $1.9M |
| August 14, 2026 | Chernett Jorey10% owner | Bought | 12,000 | $78.5K |
| July 27, 2026 | Johnson Karen MarieDirector | Received as pay | 31,124 | - |
| July 27, 2026 | Hively BradDirector | Received as pay | 27,108 | - |
| July 27, 2026 | Tzoumakas Kimberly JoDirector | Received as pay | 29,116 | - |
| July 27, 2026 | Stolper MarkDirector | Received as pay | 31,124 | - |
| July 27, 2026 | Pacala Mark LDirector | Received as pay | 30,120 | - |
| July 27, 2026 | McGeorge AnneDirector | Received as pay | 41,165 | - |
| July 27, 2026 | Kaushal MohitDirector | Received as pay | 33,133 | - |
Who owns TOI
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Chernett Jorey13G, passive | 10.2% | March 16, 2026 |
Largest institutional holders
Insiders
8 insiders reported holding 12,320,634 shares in total, about $63.2M at the last price.
| Holder | Shares |
|---|---|
| Chernett Jorey10% owner | 10,660,858 |
| Hively BradDirector | 411,976 |
| McGeorge AnneDirector | 332,535 |
| Johnson Karen MarieDirector | 319,410 |
| Pacala Mark LDirector | 286,881 |
| Kaushal MohitDirector | 205,716 |
| Stolper MarkDirector | 56,957 |
| Tzoumakas Kimberly JoDirector | 46,301 |
Questions about TOI
What does Oncology Institute, Inc. do?
Oncology Institute, Inc. is registered with the SEC under industry code SIC 8011 (Services-Offices & Clinics of Doctors of Medicine). Its shares trade on NASDAQ under the ticker TOI.
Is Oncology Institute, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $36.3M on revenue of $587.2M.
How much revenue does Oncology Institute, Inc. make?
Over the twelve months to June 30, 2026 Oncology Institute, Inc. reported revenue of $587.2M. That is 38.4% more than a year earlier.
When did Oncology Institute, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the executive or director change from September 2, 2026.
Similar companies
Compare TOI with
Follow TOI
Get an email when Oncology Institute, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow TOI: get an email when it filesWhere the numbers come from
Financial figures are the values Oncology Institute, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.